Related articles

Experts share their insights on different health topics and how comprehensive healthcare solutions can treat different conditions to improve patient health.

Immunotherapy: cutting-edge technologies and applications in cancer care

Immunotherapy has become a breakthrough approach in cancer care, offering new hope for patients by utilizing the body’s immune system to fight cancer. Unlike traditional chemotherapy or radiotherapy, immunotherapy focuses on enhancing the immune system’s ability to recognize and destroy cancer cells. This article will explore the basic principles of immunotherapy, various treatment methods, and its application in cancer management, as well as how testing can help assess the status of the immune system for more accurate treatment decisions.

Read More »

Cancer care: the potential of alternative complementary therapies

As the exploration of cancer care methods continues, more patients and healthcare providers are seeking options beyond traditional treatments. Alternative therapies, such as natural therapies and Gerson therapy, have attracted significant attention because they can, in some cases, serve as complementary approaches that enhance the effectiveness of cancer care, reduce side effects, and improve patients’ quality of life. This article will explore the basic concepts, mechanisms, and potential roles of natural therapies and Gerson therapy in cancer care.

Read More »

Exploring the Potential Role of VascuStatin in Cancer Care

VascuStatin is a natural peptide derived from the prolactin precursor protein, gaining attention in the field of oncology due to its potential anti-angiogenic properties. Anti-angiogenesis refers to the process of inhibiting the formation of new blood vessels in tumors, thereby weakening the tumor’s nutrient supply and growth potential. This article explores the potential applications of VascuStatin in cancer care, as well as key findings from experimental and clinical research.

Read More »

Onco-D-clare: Accurate and personalized cancer risk screening tool

Cancer is a multifactorial disease influenced by genetic, environmental, and lifestyle factors. With advancements in molecular biology and genetic technologies, personalized medicine is becoming a cornerstone of early cancer detection and management. Onco-D-clare, an advanced cancer risk assessment tool, integrates genetic data analysis and molecular diagnostics to provide a comprehensive understanding of individual cancer risks. This article explores the principles, applications, and potential impact of Onco-D-clare on cancer risk management.

Read More »

Air Pollution PM2.5: Cancer Risk and Everyday Protection

PM2.5 (particulate matter less than 2.5 micrometers in diameter) refers to tiny airborne particles that can penetrate deep into the lungs and even enter the bloodstream. These minuscule particles, primarily originating from vehicle emissions, industrial activities, and household combustion, are a major health concern. Long-term exposure to PM2.5 has been linked to various health issues, including respiratory diseases, cardiovascular diseases, and cancer. In recent years, growing evidence suggests a significant association between PM2.5 exposure and the development of certain types of cancer, particularly lung cancer, bladder cancer, and colorectal cancer.

Read More »

Common Enemy: The Interwoven Risks of Cardiovascular Diseases and Cancer

Cardiovascular diseases (CVD) and cancer are two of the most significant health threats in modern society. These two diseases often influence each other and present a substantial shared risk of co-occurrence globally. Although they have different pathological mechanisms and clinical manifestations, the intersection between them—especially in terms of risk factors, treatment strategies, and patient outcomes—has garnered increasing attention.

Read More »

How to choose between CTC and ctDNA in cancer detection?

The continuous advancement of cancer detection technology has provided more options for the formulation of precision care and personalized plans. Among them, circulating tumor cells (CTC) and circulating tumor DNA (ctDNA), as two core liquid biopsy technologies, have attracted much attention due to their unique advantages. However, in practical applications, how to choose appropriate detection methods based on the patient’s specific situation and care goals has become a key issue. This article will explore in depth the characteristics, applicable scenarios, and application potential of CTC and ctDNA in cancer care.

Read More »

Peptide therapy: a revolutionary approach in cancer adjuvant therapy and rehabilitation treatment

Peptide therapy has gradually become a promising option in the adjuvant treatment and rehabilitation stages of cancer. Peptides are molecules composed of short chains of amino acids that play important roles in a variety of biological processes, such as cell signaling, hormone production, and immune system regulation. In adjuvant cancer therapy, certain peptides show potential to target cancer cells, reduce tumor growth, and enhance the body’s natural immune response. This article will explore how peptide therapy can be an effective adjunct to cancer treatment, highlight why peptide therapy supplements are superior to natural sources, and review the scientific research supporting their use.

Read More »

Immunoglobulins and cancer

Immunoglobulin, commonly known as antibodies, are proteins produced by the immune system to identify and neutralize harmful substances such as bacteria, viruses, and abnormal cells. Derived from human plasma, immunoglobulin therapy is designed to boost or modulate the immune system, supporting the body in its fight against diseases, including cancer.

Read More »

Formaldehyde’s carcinogenic potential: scientific research and health warnings

Formaldehyde is a common volatile organic compound (VOC) widely used in construction materials, furniture manufacturing, and cosmetics. It is also a natural byproduct of combustion processes, such as cooking and smoking. Despite its widespread applications, formaldehyde is a recognized health hazard and has been classified as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC).

Read More »